Evidence map›Paper›PMID 40594826›Full record

ArticleScientific reports2025

Lamina cribrosa morphology and clinical implications in glaucoma with thin central corneal thickness.

Sang Muk Lee, Min Seon Park, Garam Shin, Sung Uk Baek

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sang Muk LeeDepartment of Ophthalmology, Hallym University College of Medicine, Anyang, Korea.
Min Seon ParkDepartment of Ophthalmology, Hallym University College of Medicine, Anyang, Korea.
Garam ShinDepartment of Ophthalmology, Hallym University College of Medicine, Anyang, Korea.
Sung Uk BaekDepartment of Ophthalmology, Hallym University College of Medicine, Anyang, Korea. postharuto@hanmail.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the relationship between thin central corneal thickness (CCT) and lamina cribrosa (LC) morphology in patients with normal-tension glaucoma. Thin CCT was defined as a corneal thickness of less than 500 μm in both eyes, and all included patients had a corrected intraocular pressure of less than 20 mmHg. To investigate the LC-morphological characteristics observed in the Thin-CCT group (N = 60), the Normal-CCT group (N = 36) was set as the control. A subgroup analysis was performed on Progressors and Non-progressors using the visual field's progression rate to identify progression-related risk factors. The LC posterior displacement index was higher in the Thin-CCT group and the temporal anterior laminar insertion depth (ALID) was deeper in Progressors. In multivariate analyses, the risk of glaucoma progression increased with older age, thinner CCT, worse visual filed, deeper temporal ALID, and deeper mean LC depth. Notably, ALID showed a significant correlation with CCT. These findings suggest that in patients with normal-tension glaucoma, thinner CCT is associated with a more pronounced posterior displacement and deeper insertion of the LC, even under similar intraocular pressure conditions. The altered LC morphology observed in thin CCT may help explain the higher rate of glaucoma progression in this patient population.

Indexed as

CorneaGlaucomaLow Tension GlaucomaOptic DiskAdultAgedDisease ProgressionFemaleHumansIntraocular PressureMaleMiddle AgedRisk FactorsTomography, Optical CoherenceVisual FieldsAnterior laminar insertion depthCentral corneal thicknessLamina cribrosaPosterior displacement index

Identifiers

PMID40594826
PMCPMC12219414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.